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Abstract 
The presence of Extended Spectrum Beta Lactamase (ESBL) producing organisms in abattoirs, a non-hospital 
community was investigated. A total of ten (10) isolates of Pseudomonas species out of twenty-six bacteria isolates 
expressing ESBL was obtained. The anti-pseudomonal activities of various solvent fractions of Milletia aboensis 
against the ESBL positive isolates of Pseudomonas species showed varying sensitivity. These results have suggested 
that Milletia aboensis   possess potent anti-pseudomonal agents that could be used to treat infections due to 
Pseudomonas species expressing ESBL. These anti-pseudomonal metabolites are located in the ethanol, chloroform 
and methanol fractions but are absent in the ethyl acetate fractions. 
Keywords: Extended Spectrum Beta Lactamase, Milletia aboensis, Pseudomonas species 
1.0  Introduction 
The emergence of antibiotic resistance among prevalent pathogens is a serious threat to the management of 
infectious disease. Beta-lactam (β-lactam) antibiotics are commonly used for the treatment of bacterial infections [1]. 
However the development of resistance to this class of antibiotics by bacteria through production of β-lactamases is 
the main mechanism of bacterial resistance to these antibiotics [2]. The extended-spectrum β-lactams became widely 
used in the treatment of serious infection due to Gram-negative bacteria [3] after failure of the Beta-lactams. However, 
resistance to these extended spectrum β-lactams due to β-lactamases emerged quickly [3, 4]. The first report of 
plasmid-encoded β-lactamases capable of hydrolyzing the extended-Spectrum cephalosporins was published in 
1983[5]. Many Gram-negative bacteria possess naturally occurring, chromosomally mediated-lactamases, (e.g. AmpC 
cephalosporinases of Enterobacteriaceae) as well as plasmid-mediated β-lactamase e.g. TEM-1 and SHV-1[2] that 
inactivate these antibiotics.  Extended Spectrum Beta Lactamases (ESBLs) are so called because they are able to 
hydrolyze extended spectrum β-lactam antibiotics. They have ability to inactivate β-lactam antibiotics containing an 
oxyimino-group such as oxyimino-cephalosporins (e.g., ceftazidime, ceftriaxone, cefotaxime) as well as oxyimino- 
monobactam (e.g. aztreonam) [3, 6]. The enzymes are not active against cephamycins and carbapenems. Generally, 
they are inhibited by β-lactamase-inhibitors such as clavulanate and tazobactam. ESBLs have been isolated in food 
producing animals, Community and Hospital settings and among paediatrics [7-9]. 
Milletia aboensis is widely distributed in tropical Africa and found abundantly in South East of Nigeria, Cameroon 
and Equatorial Guinea. The leaves are used for general healing and as laxatives while the root is used for treatment 
of venereal diseases [7]. Traditionally, the leaves decoction has been widely used in the treatment of pains and 
inflammatory disease conditions. 
In this research therefore, the crude extracts and some solvent fractions of the crude extracts are evaluated against 
ESBL producing Pseudomonas species. The findings will enhance the search for new active ingredient(s) for the 
control of the ESBL producing pseudomonas species in particular and bacteria in general. 
1.1  Materials and Methods 
1.1.1 Isolation of ESBL producing Pseudomonas species using Double Disc Synergy Test (DDST) 
A total of twenty-nine bacteria showing ESBL positivity isolated from One hundred and forty nine (149) samples 
collected from different Cow abattoirs at Awka metropolis Anambra State Nigeria were used for the study. 
 A 20 ml volume of Mueller Hinton agar was prepared and dispensed aseptically into each of the Petri dishes. A 0.1 
ml suspension of each of the isolates equivalent to 0.5 ml MacFarland standard was aseptically seeded into the Petri 
dishes together with Mueller Hinton agar. This was allowed to stand for 1 hour to solidify. A combination disc 
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(Amoxicillin 20 µg and Clavulanic acid 10 µg) was placed at the centre of the Petri dish and antibiotics (Ceftazidime 
30 µg and Cefuroxime 30 µg) were placed 15 mm apart centre to centre on both sides of the plates. 
The set up was done in triplicate and it was left for 30 minutes for diffusion. It was incubated at 37 oC for 24 hours 
after which the various inhibition zone diameters were measured. 
1.1.2 Extraction and fractionation of the plant materials 
The fresh plant leaves were washed with clean water, then sliced into small fragments and sun-dried. The dried 
material was reduced to coarse powder with mortar and pestle and then reduced to a fine powder with a mechanical 
grinder.  
About 500 g of the pulverized leaves were cold-macerated in aqueous ethanol (70%) for forty-eight hours. The 
ethanol extract was concentrated in vacuum. The extract was adsorbed on silica gel and eluted in succession with 
Chloroform, Ethyl acetate and Methanol. All the extracts and fractions were stored in refrigerator between 0-4.oC 
until used. 
1.1.3 Sensitivity of test microorganisms to plant extracts  
This was determined by the agar well diffusion method. A 20 ml quantity of sterile molten Mueller- Hinton nutrient 
agar was poured aseptically into Petri dishes containing 0.1 ml of the McFarland’s standard of the test micro-
organisms. The plates were gently rotated to ensure even distribution of the microorganisms and finally allowed to 
set. Using sterile cork borer, wells of 6 mm diameter were bored on the solidified seeded Mueller-Hinton nutrient 
agar plates. About 40 µl of the different concentrations of herbal extract and standard antibiotics were placed in the 
wells and left for one hour at room temperature after which the plates were incubated at 37 oC for 24 hours. The test 
was carried out in triplicate for each of the ten preparations. After the incubation period, the plates were observed for 
inhibition zone diameter (IZD). 
1.1.4 Evaluation of the Minimum Inhibitory Concentration (MIC) of the plant extract 
The minimum inhibitory concentration of the extracts and standard antibiotics against Pseudomonas species 
expressing ESBL were performed using the agar dilution method.  A 19 ml volume of sterilized Mueller-Hinton 
nutrient agar was aseptically poured into a sterile Petri dish containing 1 ml of the graded concentration of the eight 
different preparations of the extracts. The plates were rotated to ensure an even distribution of the microorganisms 
and allowed to set. The plates were inoculated with a loopful of 0.5 McFarland standards of the test microorganisms. 
This was repeated for all the test microorganisms and each done in duplicates. The plates were incubated at 37 oC for 
24 hours for all species of the ESBL producing Pseudomonas. Presence of growth was observed after incubation and 
the MIC recorded as the minimum concentration where no visible growth was observed on the plate. 
1.2    Results and Discussions 
The ethanol extract of Milletia aboensis has a yield of 86.74 g. The chloroform fraction had a yield of 8.46 g, the 
ethyl acetate fraction gave a yield of 5.48 g and that of methanol fraction was 35.46 g.  
Phenotypic methods of detection of ESBL activity is based upon the resistance that ESBLs confer to oxyimino- β- 
lactams (e.g ceftriaxone, cefotaxime, ceftazidime and aztreonam) and the ability of a β-lactamase inhibitor, usually 
clavulanate, to block this resistance. A clear extension of the edge of the antibiotic’s inhibition zone toward the disk 
containing clavulanate is interpreted as synergy, indicating the presence of an ESBL.  
Table 1 thus shows high ESBL production with the organisms depicting the synergistic symbol that is characteristic 
of ESBL production appearing to be Pseudomonas species. ESBLs have been found in a wide range of gram-
negative rods. However, the vast majority of strains expressing these enzymes belong to the family 
Enterobacteriaceae [3].  Klebsiella   pneumonia seems to remain the major ESBL producers. Another very important 
organism is Escherichia coli. It is important to note the growing incidence of ESBLs in Salmonella sp [8].  ESBLs 
have become more prevalent among species with inducible AmpC β- lactamases [9]. 
Non Enterobacteriaceae ESBL producers are relatively rare with Pseudomonas aeruginosa   being the most 
important organism [10]. ESBL has also been reported in Acinetobacter spp, Burkholderia cepacia and Alcaligenes 
fecalis [3].  
Some solvent fraction of Milletia aboensis showed an appreciable level of antibacterial activity on the Pseudomonas 
spp producing ESBL (Table 2). Both the crude ethanol extract and methanol fraction showed appreciable activity 
against ESBL Pseudomonas isolates at the concentration of 25mg/ml and 12.5mg/ml respectively (Table 2). It was 
also observed that the activity increases as the concentration decreases which could be attributed to diffusion 
problems. Also, table 2 revealed that the crude extract of Milletia aboensis had no effect against two species of 
Pseudomonas (putida and fulva) while there are observable zones of inhibition when evaluated against P.monteilli, 
P.beteli and P.mendocina. There are zones of inhibition across the entire organisms challenged with the methanol 
extract of Milletia aboensis at the concentration ranges of 50mg/ml-12.5mg/ml. 
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Chloroform fraction exhibited antibacterial activity at the highest concentration (Table 2) while ethyl acetate showed 
no significant effect against the test ESBL isolates. 
From table 3, the MIC of the Crude (ethanol) leaf extracts as well as the chloroform and methanol fractions of the 
extracts of Milletia aboensis against the positive test ESBL isolates of Pseudomonas species were shown. The 
ethanol extract had the lowest MIC value of 10 mg/ml. This could imply that the metabolites with highest activity 
may lie within the ethanol extract or that group of metabolites act synergistically to give a better performance than 
either the chloroform or methanol fractions.  
 
Conclusion 
The ESBL positive Pseudomonas species isolated are sensitive to metabolites found in the ethanol, chloroform and 
methanol fractions of Milletia aboensis. 
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Table 1: Phenotypic confirmation of ESBL producing Pseudomonas spp  
                                 CAZ      CAZ+AMC           CTX            CTX+AMC 
 
P. monteilli                 0                29                        0                      30 
 
P. putida                    21                28                       0                      22 
 
P. beteli                     17                28                       0                      28 
 
P. mendocina            11                20                      13                      27 
 
P. putida                   15                28                        0                      21 
 
P. monteilli                 0                31                        0                      23 
 
P. monteilli               15                33                        0                      22 
 
P. putida                   19                29                       11                      25 
 
P. monteilli                 0                30                       13                      29 
 
P. fulva                     21                34                         0                       24 
 
P. putida                   24                28                       11                       30 
 
P. monteilli                 0                31                         0                       24 
 
P. fulva                     21                29                       14                       29 
 
P. mendocina             0                22                         0                        22 
CAZ = Ceftazidime; CTX = Cefotaxime; AMC = Amoxicillin+ Clavulanic acid 
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      Table 2: Sensitivity of solvent fractions of Milletia aboensis against Pseudomonas species expressing ESBL 
        Extract  Conc                           Zone of Inhibition (mm) 
                          (mg/ml)       B1        B2        B3        B4        B5        B6        B7        B8        B9        B10 
                             Crude             200                 0          0           0           0          0           0          0           0           0            0 
                                                    100                 0          0           0           0          0           0          0           0           0            0           
                                                      50                 0          0           6           0          0           0          0           0           0            0 
                                                      25                 7          9           7          10         0           0          6           0           0            6 
                                                      12.5              8        10          10         12         0           0          7           0           0            6       
                             Methanol        200                 0          0           0           0          0           0          0           0           0            0 
                                                     100                 0          7           0           0          0           0          0           0           0            0 
                                                       50                 0          8           0           0          0           9          0           0           0            0 
                                                       25                 7          8           4           6          8          14         8           7           0            6 
                                                       12.5            12        15         10         11        10         16        13         15          8           11 
                               Chloroform   1000              8           8           8           6          0           9        10          0            6          11 
                                                     500                0           0           0           0          0           0         0           0            0           0              
                                                     250                0           0           0           0          0           0         0           0            0           0 
                                                     125                0           0           0           0          0           0         0           0            0           0 
                                                       65.5             0           0           0           0          0           0         0           0            0           0 
                              Ethylacetate   250                0           0           0          0           0           0         0           0            0           0 
                                                     100                0           0           0          0           0           0         0           0            0           0         
                                                       50                0           0           0          0           0           0         0           0            0           0 
                                                       25                0           0           0          0           0           0         0          0             0           0 
                             12.5              0           0           0          0           0           0         0          0             0           0 
 *Each value represents the mean value of two determinants. B1= Pseudomonas monteilli, B2=P. 
putida,B3=P.beteli, B4= P. mendocina, B5= P. putida, B6= P. monteilli, B7= P. monteilli, B8= P. 
Putida, B9= P. fulva, B10= P. mendocina  
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Table 3: Minimum inhibitory concentrations of solvent fractions of Milletia aboensis against 
Pseudomonas species expressing extended spectrum beta lactamase  
Isolates                      Minimum Inhibitory Concentration (mg/ml) 
                              CEMA          CFMA         MFMA       GEN (µg/ml)   
B1                              10                  50               50                   0.15 
B2                              10                 50                50                   0.15 
B3                              10                 50                50                   0.15                    
B4                              10                 50                50                   0.15 
B5                              10                 50               50                    0.15 
B6                              10                 50               50                    0.15 
B7                              10                 50               50                    0.15 
B8                              10                 50               50                    0.15 
B9                              10                 50               50                    0.15 
B10                            10                 50               50                    0.15   
*Each value represents the mean value of two determinants. B1= Pseudomonas monteilli, B2=P. 
putida, B3=P.beteli, B4= P. mendocina, B5= P. putida, B6= P. monteilli, B7= P. monteilli, B8= P. 
Putida, B9= P. fulva, B10= P. mendocina. CEMA= Crude Extract of Milletia aboensis, CFMA= 
Chloroform Fraction of Milletia aboensis, MFMA= Methanolic Fraction of Milletia aboensis, 
GEN = Gentamycin 
 
